探索铁补充剂配方方法在治疗缺铁性贫血的进展,通过文献计量和专题分析
Tarnjot Kaur1, Jyoti Upadhyay1, Mukesh Nandave2
1Department of Pharmaceutical Sciences, School of Health Sciences and Technology, UPES, Bidholi Campus, Dehradun 248007, Uttarakhand, India.
Heliyon
|April 16, 2024
概括
贫血治疗铁制剂的研究趋势显示,自2010年以来,人们越来越关注新的策略. 全球需要一种更安全,更有效的缺铁性贫血治疗方法.
科学领域:
- 图书计量和健康科学 图书计量和健康科学
- 药理学和药物开发领域
- 公共卫生和流行病学
背景情况:
- 贫血影响全球三分之一的人口,强调需要有效的治疗方法.
- 缺铁性贫血 (IDA) 是一个重要的全球健康问题,需要改进治疗策略.
- 目前IDA的处理方法需要在铁配方方面取得进展.
研究的目的:
- 对治疗缺铁性贫血的铁制剂的研究趋势进行文献计量分析.
- 为IDA调查口服和肠外铁配方方面的进展.
- 为IDA治疗策略的演变提供见解.
主要方法:
- 从1977年到2022年,对543篇研究论文进行了图书统计和专题分析,来源于Scopus.
- 使用R工具的Bibliometrix套件进行文献识别分析.
- 研究了出版趋势,地理贡献,附属关系,期刊影响,引用网络和协作模式.
主要成果:
- 从2010年开始,观察到IDA配方策略研究的显著增加.
- 美国,意大利,印度,德国和英国是主要贡献者;营养学期刊占主导地位.
- 关键的研究领域包括怀孕中的IDA,慢性病,炎症性肠病和静脉注射铁配方.
结论:
- 越来越多的研究表明,需要更安全,更有效的铁配方来对抗贫血患病率.
- 结果指导未来的研究和开发创新的IDA治疗方法.
- 洞察力可以为公共卫生政策和研发投资提供信息,用于新型铁疗法.
相关概念视频
Erythropoiesis
4.2K
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
4.2K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K


